Evidence map›Paper›PMID 30091082›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2019

Plasma FGF23 does not rise during physical exercise as a physiological model of sympathetic activation.

Insa E Emrich, Marc Baier, Adam M Zawada, Tim Meyer, Danilo Fliser, Jürgen Scharhag, Gunnar H Heine

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Sharp rises in FGF23 and hypophosphatemia after intravenous iron administration do not cause myocardial damage.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Insa E EmrichInternal Medicine IV, Nephrology and Hypertension, Saarland University Medical Center, Homburg, Germany. insa.emrich@uks.eu.
Marc BaierInternal Medicine IV, Nephrology and Hypertension, Saarland University Medical Center, Homburg, Germany.
Adam M ZawadaInternal Medicine IV, Nephrology and Hypertension, Saarland University Medical Center, Homburg, Germany.
Tim MeyerInstitute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany.
Danilo FliserInternal Medicine IV, Nephrology and Hypertension, Saarland University Medical Center, Homburg, Germany.
Jürgen ScharhagInstitute of Sports and Preventive Medicine, Saarland University, Saarbrücken, Germany.
Gunnar H HeineInternal Medicine IV, Nephrology and Hypertension, Saarland University Medical Center, Homburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersCardiovascular DiseasesExerciseFibroblast Growth Factor-23Fibroblast Growth FactorsHealthy VolunteersHumansMaleRenal Insufficiency, ChronicSympathetic Nervous SystemYoung AdultBiomarkersFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth Factors

Identifiers

PMID30091082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.